Introduction
Patients with acromegaly have significantly higher levels of growth hormone (GH) and insulin-like growth factor-1 (IGF-1) than normal healthy individuals; over 95% of these higher levels are caused by pituitary growth hormone-secreting adenoma. High levels of GH and IGF-1 promote the hyperplasia of bone and soft tissue around the airways, causing anatomical structural changes of the respiratory tract and secondary respiratory dysfunction [1] . Therefore, respiratory dysfunction is a common complication of patients with acromegaly. In addition, changes in the structure of the skull and thickening of the upper airway soft tissue such as the pharyngeal wall, soft palate and tongue can cause upper airway stenosis, which contributes to the development of obstructive sleep apnea-hypopnea syndrome (OSAHS) and aggravates airway difficulty during anesthesia in patients with acromegaly.
There are few studies on the lower airway and lung function of patients with acromegaly. Studies have shown that high GH and IGF-1 levels can increase the left and right main bronchial diameter in addition to causing graded bronchus and bronchiole wall thickening, lung compliance decline, small airway stenosis, etc. [2] . However, most of the previous studies were small sample studies, in which the clinical relevance of many indicators was highly inconsistent. The studies could not provide definitive clinical guidance. Störmann and other researchers published an article in the https://doi.org/10.1016/j.jocn.2020.01.003 0967-5868/Ó 2020 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Abbreviations: GH, growth hormone; IGF-1, insulin-like growth factor-1; FVC, forced vital capacity; FEV1, forced expiratory volume in one second; PEF, peak expiratory flow; MEF75, maximum flow rate at 75% of vital capacity; MEF50, maximum flow rate at 50% of vital capacity; MEF25, maximum flow rate at 25% of vital capacity; TSH, thyroid-stimulating hormone; T4, thyroxine; FT4, free thyroxine; T3, triiodothyronine; FT3, free triiodothyronine; ACTH, adrenocorticotropic hormone; F, free cortisol; PaO 2 , partial arterial oxygen pressure; PaCO 2 , arterial partial pressure of carbon dioxide; HCO 3 À , plasma bicarbonate concentration; SaO 2 , oxygen saturation; ABE, actual base excess; AG, anion gap; Lac, lactate; OSAHS, obstructive sleep apnea-hypopnea syndrome.
European Journal of Endocrinology (EJE) in 2017; the study included 109 patients with acromegaly and studied the main indexes of lung function. The results showed that patients with acromegaly had larger lung volumes and small airway obstruction. Although this is currently the largest investigation of lung function in acromegaly patients, the normative date was set as a comparison instead of a control group. Several studies have shown that changes in airway structure can affect the partial pressure of oxygen in the airway [3] , and hypoxemia can occur in patients with upper airway obstruction [4] . Although there are changes in airway structure in acromegaly patients and some patients even have airway stenosis, the study of blood gas in acromegaly patients remains controversial. A study confirmed that the mean partial blood oxygen pressure in patients with acromegaly was significantly lower than expected [5] . Hypoxemia may also be associated with long-term oversecretion of GH [6] . However, other studies have shown that there is no significant difference in arterial partial pressure of oxygen or partial pressure of carbon dioxide (PaCO 2 ) between acromegaly patients and nongrowth hormone adenoma patients [7] .
Our cohort comprised 115 acromegaly patients and 56 patients with nonfunctioning pituitary adenoma with normal GH levels as controls. We compared the differences in lung volume, lung function and blood gas between the patients with acromegaly and nonfunctioning adenomas. The baseline differences between patients with abnormal pulmonary function and patients with normal pulmonary function were compared in patients with acromegaly to provide clinical guidance for perioperative management of acromegaly patients.
Methods

Study population
All patients with GH-secreting adenoma and nonfunctioning adenoma underwent pituitary adenoma surgery in the neurosurgery department of Peking Union Medical College Hospital from June 2016 to June 2018. Inclusion criteria: 1) According to the Journal of Clinical Endocrinology and Metabolism (JCEM) Guidelines from 2014 [8] and the Journal of the American Medical Association (JAMA) Guidelines in 2017 [9] , patients with typical clinical manifestations, image examinations and laboratory tests demonstrating acromegaly or nonfunctioning pituitary adenoma were enrolled in this study. 2) Adults over 18 y of age, including men and women. Exclusion criteria: Patients with a history of primary pulmonary disease and patients using glucocorticoids, betareceptor agonists, theophylline or other drugs for respiratory diseases.
Experimental design
Each patient's medical history was collected before the operation, including age, sex, height, weight, and past medical history (including diabetes, hypertension, heart disease, hepatitis, and surgical history). The lung function test (forced vital capacity (FVC), forced expiratory volume in one second (FEV1), FEV1/FVC, peak expiratory flow (PEF), maximum flow rate at 75% of vital capacity (MEF75), MEF50, MEF25), hormone level test (GH, IGF-1, thyroidstimulating hormone (TSH), triiodothyronine (T3), thyroxine (T4), sex hormone, adrenocorticotropic hormone (ACTH), free cortisol (F)) and blood gas test (pH, partial arterial oxygen pressure (PaO 2 ), PaCO 2 , plasma bicarbonate concentration (HCO 3 À ), oxygen saturation (SaO 2 ), actual base excess (ABE), standard base excess (SBE), anion gap (AG), lactate (Lac)) were conducted before the operation.
Lung function assessment
The lung functions of all patients were examined in the lung function room of Peking Union Medical College Hospital before operation. According to the American Thoracic Society (ATS) Guidelines [10] , we tested the following parameters through the Jaeger Masterscreen system (Jaeger Co., Hchberg, Germany): maximum respiratory flow volume loop, FEV1, FVC, PEF, MEF75, MEF50, and MEF25. Patients whose actual value of FEV1 was less than 80% of the predicted value were considered to have obstructive pulmonary dysfunction [11] . MEF25, MEF50 and MEF75 were used to measure the small airway function. Actual values of MEF75 and MEF50 no less than 75% of the predicted value are within the normal range. Patients outside the range were considered to have small airway obstructive dysfunction [12] . The increase in lung volume was considered when FVC exceeded the expected value by 120% [13] .
Hormone and radiological assessments
The levels of serum GH and TSH were detected by immunochemiluminometric assays (Beckman, USA). The levels of IGF-1 were detected by chemiluminescence assays (IMMULITE 1000). Serum levels of T4, free thyroxine (FT4), T3 and free triiodothyronine (FT3) were detected by enzyme-linked immunosorbent assay (ELISA). Blood ACTH, F, follicle-stimulating hormone (FSH), luteinizing hormone (LH), 17b-estradiol (E2), progestin (P) and prolactin (PRL) levels were measured by radioimmunoassay. Arterial blood was collected 24 h before the operation. Blood gas parameters including pH, PaO 2 , PaCO 2 , methemoglobin, HCO 3 À , SaO 2 , alveolar and arterial oxygen tension gradient (PaO 2 (A-a)), ABE, SBE, AG and Lac were measured by a Rapidlab 1200 blood gas analyzer (Germany).
Statistical analysis
SPSS software (version 17.0, IBM, USA) was used for data analysis. The results are shown as the mean ± standard deviation and range. A t-test was used to compare independent continuous variables among groups. A chi-square test was used to analyze the distribution of classification variables. P < 0.05 was considered statistically significant.
Results
A total of 171 patients were enrolled in this study, including 115 patients with GH-secreting pituitary adenoma and 56 patients with nonfunctioning adenoma. Table 1 summarizes the basic clinical features of patients with GH-secreting adenoma and nonfunctioning adenoma. The average age of patients with GH-secreting adenoma (42.41 ± 12.17 y.o.) was lower than that of patients with nonfunctioning adenoma (51.18 ± 15.13 y.o., P < 0.001). However, the average weight of patients with GH-secreting adenoma (75.6 0 ± 14.66 kg) was higher than that of patients with nonfunctioning adenoma (69.29 ± 11.02 kg, p = 0.002). In terms of underlying diseases, the number of diabetes mellitus patients (n = 26) in the group of acromegaly patients was higher than that in the group of nonfunctioning adenoma patients (n = 2, p = 0.001), but there was no significant difference in the proportion of hypertension patients between the two groups (p = 1.000). Among the patients with recurrent pituitary adenomas, 32 had GH-secreting adenomas and 6 had nonfunctioning adenomas. Recurrent pituitary GHsecreting adenoma patients included those who relapsed after pituitary adenoma resection (n = 16) and those who relapsed after radiotherapy (n = 16). The proportion of recurrent GH-secreting adenoma patients was significantly higher than that of nonfunctioning adenoma patients (p = 0.011).
The anterior pituitary hormone test showed that the level of GH in patients with acromegaly (32.70 ± 45.21) was significantly higher than that in patients with nonfunctioning adenoma (0.52 ± 1.04, P < 0.001). The level of TSH in patients with acromegaly (1.41 ± 1.18) was lower than that in patients with nonfunctioning adenoma (3.01 ± 5.14, p = 0.001), and the levels of T3, T4, FT3 and FT4 in patients with acromegaly were higher than those in patients with nonfunctioning adenoma (p < 0.05). There were no significant differences in gonadal axis hormone levels between the two groups (p > 0.1). The ACTH level in patients with GHsecreting adenoma was significantly higher than that in patients with nonfunctioning macroadenoma (41.01 ± 55.87), but there was no significant difference in the serum cortisol level between the two groups (p > 0.05). Although the average levels of thyroid axis hormone and adrenal axis hormone were significantly different between the two groups, they were still within the normal range. Table 2 compares the pulmonary function of patients with acromegaly with that of patients with nonfunctioning adenoma, showing differences in lung volume and airway obstruction between the two groups. The FVC value (p < 0.001) and FVC% predicted (p < 0.001) of patients with acromegaly were significantly higher than those of patients with nonfunctioning adenoma. There was no significant difference in FEV1/FVC between the two groups when measuring the degree of airway obstruction (p = 0.151); FEV1% predicted (p < 0.001), PEF% predicted (p = 0.001), MEF75% predicted (p < 0.001), MEF50% predicted (p < 0.001), and MEF25% predicted (p = 0.001) were lower in patients with nonfunctioning adenoma than in patients with acromegaly. Table 3 compares the parameters of blood gas between the two groups. The arterial blood pH of patients with acromegaly was lower than that of patients with nonfunctioning pituitary adenoma (p = 0.021). The level of PaCO 2 in acromegaly patients was higher (p < 0.001), but there was no significant difference between the level of partial pressure of oxygen (p = 0.968). The HCO 3 À in patients with acromegaly (24.91 ± 1.95) was higher than that in patients with nonfunctioning adenoma (23.70 ± 1.51, p = 0.012). There was no significant difference in SaO 2 or alveolar-arterial oxygen partial pressure between the two groups (p > 0.05). In this study, patients with MEF75% predicted and MEF50% predicted no less than 75% were considered to have normal small airway function. Of the 115 patients with acromegaly, 32 (27.8%) had small airway obstructive dysfunction. Table 4 compares baseline information between acromegaly patients with small airway obstruction and patients with normal small airway function. The average age of patients with small airway obstruction (46.66 ± 13. 19) was higher than that of patients with normal lung function (40. 77 ± 11.41, p = 0.019). However, there was no significant difference in average weight, GH level or IGF-1 level between the two groups (p > 0.05). In patients with acromegaly, there was no significant difference in GH or IGF-1 levels between patients with increased lung volume and patients with normal lung volume (p > 0.05) ( Fig. 1) .
Discussion
This study confirmed that patients with GH-secreting adenoma had higher lung volume than those with nonfunctioning adenoma, and the degree of small airway obstruction in patients with GHsecreting adenoma was lower than that in the control group. The average PaCO 2 in patients with acromegaly was higher than that in the control group, but there was no significant difference in the average partial pressure of oxygen or SaO 2 between the two groups. In acromegaly patients, the average age of patients with small airway obstruction was higher than that of patients with normal lung function, but there was no significant difference in GH or IGF-1 levels between the two groups. There was no signifi- cant difference between patients with acromegaly with increased lung volume and patients with normal lung volume. In a previous study, Stormann et al. [5] studied the main parameters of lung function in 109 patients with acromegaly and suggested that acromegaly patients had a larger lung volume than healthy controls. In a study involving 35 patients with acromegaly, 34% of patients had increased lung volume [14] . Our study also confirmed that the FVC value and FVC% predicted in acromegaly patients were significantly higher than those in patients with nonfunctioning adenomas. This finding indicates that the lung volumes of patients with acromegaly in this cohort were higher than those of patients in the control group. Many factors can explain the increased lung volume in acromegaly patients. Glaser et al. [15] showed that increased lung volume in men is associated with increased levels of IGF-1. However, it was not confirmed that increased lung volume was associated with levels of IGF-1 or GH in female patients under 50 y of age [15] . In our cohort, there was no significant difference in GH or IGF-1 levels between patients with enlarged lung volume and those with normal lung volume. In addition, it has also been confirmed that the increase in the number of alveoli is one of the reasons for the increase in lung volume, while the size of the alveoli in patients with acromegaly is still within the normal range [16] .
In patients with acromegaly, the FEV1% predicted value was significantly higher than that in patients with nonfunctioning adenoma. We also compared small airway function-related parameters, such as PEF% predicted, MEF75% predicted, MEF50% predicted and MEF25% predicted. The average value in acromegaly patients was higher than that in nonfunctioning adenoma patients. This finding indicates that the average degree of airway obstruction in patients with acromegaly is lower than that in patients with nonfunctioning adenoma. Brody et al. [17] also confirmed that patients with acromegaly had no lower airway obstruction. However, Trotman-Dickenson et al. [14] conducted a study with 35 patients with acromegaly and found that 8 patients had lower airway obstruction. However, this study was a relatively small cohort study, and 50% of patients had upper airway obstruction. Upper airway obstruction is the main cause of abnormal lung function in acromegaly patients. Stormann et al. [5] showed that patients with acromegaly had airway obstruction, and their average value of MEF25 was significantly lower than that of healthy controls. However, there was no significant difference in the average values of MEF75 and MEF50 between their cohort and healthy controls (P > 0.05). Moreover, the average age of patients in this cohort was 54.6 y, which was significantly higher than that in our cohort (42.4 y). The decrease in MEF25 may be related to the increase in patient age [5] .
In patients with acromegaly, we compared baseline information between patients with small airway obstruction and those with normal airway function. The average age of patients with airway obstruction was higher than that of patients with normal airway function, but there was no significant difference in GH or IGF-1 levels. This finding suggests that age is one of the factors affecting small airway function, but GH and IGF-1 levels have no significant effect on small airway function. Previous studies also indicated that GH and IGF-1 levels did not affect lung function in patients with acromegaly [18] . Obstructive disease and decreased air flow were observed in elderly patients in a study on pulmonary function and structure [19] . Therefore, small airway obstruction in patients with acromegaly may be related to age. Therefore, airway difficulty [7] and small airway obstruction should be considered in the contexts of anesthesia and operation of elderly patients with acromegaly.
We compared the mean blood gas parameters between patients with acromegaly and patients with nonfunctioning adenoma. There was no significant difference in partial arterial oxygen pressure between the two groups, and the average value was within the normal range, indicating that there was no hypoxemia in patients with acromegaly. The PaCO 2 and HCO 3 À in patients with acromegaly were higher than those in the control group. Rodrigues et al. [20] measured and analyzed the blood gas of 36 patients with acromegaly. Seven of them had hypoxemia, but most of the cases of hypoxemia could be explained by underlying diseases [20] . In one study, 8 out of 11 patients with acromegaly had hypoxemia, with an average partial arterial oxygen pressure of 76 mmHg [6] .
Although the risk of hypoxemia in patients with acromegaly is still controversial, untreated acromegaly patients can also develop OSAHS [21] , so acromegaly still requires early diagnosis and treatment.
Conclusion
This study confirmed that acromegaly patients had increased lung volume. However, there was no evidence demonstrating the existence of hypoxemia in acromegaly patients. The small airway in acromegaly patients was less obstructive. Small airway obstruction was observed in elderly patients with acromegaly.
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